Bioretec Ltd Company announcement 14 March 2025 at 7:30 p.m. EET

TAMPERE, Finland, March 14, 2025 /PRNewswire/ -- Bioretec Ltd has on 14 March 2025 received a notification in accordance with the Securities Market Act, according to which the holdings of shares and votes of W&M GmbH in Bioretec Ltd have on 14 March 2025 crossed the threshold of 5%.

Total position of W&M GmbH according to the notification:

                                                                           % of shares               % of shares and Total of
                                                                                                                      both                         Total number of
                                                                and voting             voting rights                     in % shares and voting
                                                                rights                  through
                                                                                        financial                              rights of the issuer
                                                                                       instruments



            Resulting situation on the date on which threshold                 5.78 %                           0 %   5.78 %                           24,566,474
     was crossed or reached



            Position of previous notification (if applicable)

Notified details of the resulting situation on the date on which the threshold was crossed:

                                                    
              
                Number of shares             
              
                % of shares
                                                               and voting rights                                  and voting rights





     
               Class/type of shares              Direct (SMA 9:5)              Indirect (SMA 9:6 and  Direct (SMA 9:5)              Indirect (SMA 9:6 and
                                                                                           9:7)                                                 9:7)

       ISIN code


                               
           FI4000480454        1,419,616                                   0             5.78 %                                0 %


                                                                                            1,419,616                                               5.78 %


     
               SUBTOTAL

After 14 March 2025, W&M GmbH holds 5.78% of the shares and votes.

Further enquiries

Johanna Salko, CFO, +358 40 754 8172

Certified adviser

Nordic Certified Adviser AB, +46 70 551 67 29

Bioretec in brief

Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.

Bioretec is developing the new RemeOs™ product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on value for patients through efficient healthcare. The first RemeOs™ product market authorization has been received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025. Bioretec is positioning itself to enter the addressable USD 9 billion global orthopedic trauma and spine market and to become a game changer in surgical bone fracture treatment.

Better healing - Better life. www.bioretec.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioretec/r/bioretec-ltd--notification-in-accordance-with-chapter-9--section-10-of-the-securities-market-act-on-,c4119367

View original content:https://www.prnewswire.co.uk/news-releases/bioretec-ltd-notification-in-accordance-with-chapter-9-section-10-of-the-securities-market-act-on-a-change-in-holdings-wm-gmbh-302402119.html

Tags

More Like This

Bioretec Ltd - Managers' transactions

Bioretec Ltd's Financial Statements 2024 published

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register

Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue

Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy

Bioretec Ltd's Annual Report 2024 published

Final results of Bioretec Ltd's successful rights issue

Bioretec Ltd's Annual Report and Financial Statements 2023 published